Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 754-763

  Nagaharu, Keiki ^a   Zhang, Xinhui ^a   Yoshida, Toshimichi ^a   Katoh, Daisuke ^a   Hanamura, Noriko ^a   Kozuka, Yuji ^a,b   Ogawa, Tomoko ^a   Shiraishi, Taizo ^a   Imanaka Yoshida, Kyoko ^a  

^a MIE UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; NEUTRALIZING ANTIBODY; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CONTACT; CELL MIGRATION; CELL STRAIN MCF 7; CORRELATION ANALYSIS; CYTOSOL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MEMBRANE TRANSPORT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SRC HOMOLOGY DOMAIN; STROMA; WOUND HEALING;

EID: 79951841887     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.015     Document Type: Article

References (59)

1. Savagner P: Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001, 23:912-923
2. Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890
3. Baum B, Settleman J, Quinlan MP: Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008, 19:294-308
4. Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008,14:818-829 (Pubitemid 351757205)
5. Thompson EW, Newgreen DF, Tarin D: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 2005, 65:5991-5995
6. Christiansen JJ, Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006, 66:8319-8326 (Pubitemid 44449137)
7. Tse JC, Kalluri R: Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007, 101:816-829 (Pubitemid 47040864)
8. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, Redeuilh G, Gespach C, Bracke M, Berx G: Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 2008, 130:481-494
9. Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558 (Pubitemid 41267170)
10. Avizienyte E, Frame MC: Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 2005, 17:542-547 (Pubitemid 41267169)
11. Peinado H, Olmeda D, Cano A: Snail. Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007, 7:415-428
12. Zeisberg M, Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009, 119:1429-1437
13. Orend G, Chiquet-Ehrismann R: Tenascin-C induced signaling in cancer. Cancer Lett 2006, 244:143-163 (Pubitemid 44508708)
14. Crossin KL, Hoffman S, Grumet M, Thiery JP, Edelman GM: Siterestricted expression of cytotactin during development of the chicken embryo. J Cell Biol 1986, 102:1917-1930 (Pubitemid 16078775)
15. Tucker RP, McKay SE: The expression of tenascin by neural crest cells and glia. Development 1991, 112:1031-1039 (Pubitemid 21900304)
16. Sugi Y, Markwald RR: Formation and early morphogenesis of endocardial endothelial precursor cells and the role of endoderm. Dev Biol 1996, 175:66-83 (Pubitemid 26148772)
17. Boyer AS, Erickson CP, Runyan RB: Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGFbeta signal transduction mechanisms. Dev Dyn 1999, 214:81-91 (Pubitemid 29028905)
18. Ferguson MW: Palate development. Development. 1988, 103(Suppl): 41-60
19. Kalembey I, Yoshida T, Iriyama K, Sakakura T: Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study. Int J Dev Biol 1997, 41:569-573 (Pubitemid 27368577)
20. Yoshida T, Matsumoto E, Hanamura N, Kalembeyi I, Katsuta K, Ishihara A, Sakakura T: Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol 1997, 182:421-428 (Pubitemid 27317207)
21. Ishihara A, Yoshida T, Tamaki H, Sakakura T: Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1995, 1:1035-1041
22. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T: Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch 1999, 435:496-500
23. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y, Yoshida T: Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 2003, 162:1857-1867 (Pubitemid 36613044)
24. Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, Shaw JA, Walker RA, Pringle JH, Jones JL: Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase- dependent and independent mechanisms. Breast Cancer Res 2009, 11:R24
25. Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez- Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE: Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 2008, 27:5373-5384
26. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T: Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer 2003, 105:53-60 (Pubitemid 36418485)
27. Jahkola T, Toivonen T, von Smitten K, Blomqvist C, Virtanen I: Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 1996, 69:445-447 (Pubitemid 27050519)
28. Jahkola T, Toivonen T, Virtanen I, von Smitten K, Nordling S, von Boguslawski K, Haglund C, Nevanlinna H, Blomqvist C: Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 1998, 78:1507-1513 (Pubitemid 28517549)
29. Jahkola T, Toivonen T, Nordling S, von Smitten K, Virtanen I: Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer 1998, 34:1687-1692 (Pubitemid 28474220)
30. Wirl G, Hermann M, Ekblom P, Fässler R: Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. J Cell Sci 1995, 108:2445-2456
31. Kawakatsu H, Shiurba R, Obara M, Hiraiwa H, Kusakabe M, Sakakura T: Human carcinoma cells synthesize and secrete tenascin in vitro. Jpn J Cancer Res 1992, 83:1073-1080
32. Sadot E, Simcha I, Shtutman M, Ben-Ze'ev A, Geiger B: Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc Natl Acad Sci USA 1998, 95:15339-15344
33. Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB: Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res 2006, 66:11370-11380 (Pubitemid 46009968)
34. Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, Moses HL: Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 2004, 6:R215-231
35. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005, 5:505-515 (Pubitemid 40942827)
36. Roskoski R Jr: Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005, 331:1-14
37. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG, Frame MC: Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002, 4:632-638
38. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM, Thompson EW: Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 2008, 25:629-642
39. Tarin D, Thompson EW, Newgreen DF: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000 (Pubitemid 40994379)
40. Cowin P, Welch DR: Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT. J Mammary Gland Biol Neoplasia 2007, 12:99-102 (Pubitemid 47215427)
41. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T: Expression of β-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996, 29:139-146 (Pubitemid 26264438)
42. Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, Nicholson RI, Robertson JF: E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 2001, 85:1958-1963 (Pubitemid 34775335)
43. Kovacs A, Dhillon J, Walker RA: Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol 2003, 56:318-322 (Pubitemid 37521923)
44. Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO: An immunohistochemical examination of the expression of E-cadherin, α- and β/γ-catenins, and α2-and β1-integrins in invasive breast cancer. J Pathol 1999, 187:523-529 (Pubitemid 29151992)
45. Tsuji T, Ibaragi S, Hu GF: Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009, 69:7135-7139
46. Martin D, Brown-Luedi M, Chiquet-Ehrismann R: Tenascin-C signaling through induction of 14-3-3 tau. J Cell Biol 2003, 160:171-175 (Pubitemid 36254951)
47. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL: Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000, 275:36803-36810 (Pubitemid 32002090)
48. Maschler S, Grunert S, Danielopol A, Beug H, Wirl G: Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells. Oncogene 2004, 23:3622-3633 (Pubitemid 38658429)
49. Nerlich AG, Wiest I, Wagner E, Sauer U, Schleicher ED: Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer. Anticancer Res 1997, 17:4443-4449 (Pubitemid 28081726)
50. Gao MQ, Kim BG, Kang S, Choi YP, Park H, Kang KS, Cho NH: Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J Cell Sci 2010, 123:3507-3514
51. Thomas SM, Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609 (Pubitemid 28034534)
52. Brunton VG, Avizienyte E, Fincham VJ, Serrels B, Metcalf CA 3rd, Sawyer TK, Frame MC: Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res 2005, 65:1335-1342 (Pubitemid 40270160)
53. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, Sheppard D, Oettgen P, Mercurio AM: Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005, 115:339-347 (Pubitemid 40385475)
54. Wei L, Yang Y, Zhang X, Yu Q: Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 2004, 23:9052-9061 (Pubitemid 40013072)
55. Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A: Epidermal growth factor (EGF)-like repeats of human tenascin- C as ligands for EGF receptor. J Cell Biol 2001, 154:459-468 (Pubitemid 34288473)
56. Jones PL, Crack J, Rabinovitch M: Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 1997, 139:279-293 (Pubitemid 27444098)
57. Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E, Oakeley EJ, Chiquet-Ehrismann R, Orend G: Growth promoting signaling by tenascin-C Cancer Res 2004, 64:7377-7385
58. Wenk MB, Midwood KS, Schwarzbauer JE: Tenascin-C suppresses Rho activation. J Cell Biol 2000, 150:913-920
59. Finn RS: Targeting Src in breast cancer. Ann Oncol 2008, 19:1379-1386